Longevity

FOX-04

Longevity peptide

FOX-04 is available in a 10mg vial from the CTFD master catalog.

FOX-04 10mg

FOX-04 - 10mg

Longevity peptide

$313/mo

References

  1. FOX-04 - Peptide Center guide
  2. The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRINature communications, 2025
  3. Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human ChondrocytesFrontiers in bioengineering and biotechnology, 2021
  4. FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathwayFrontiers in bioengineering and biotechnology, 2025
  5. FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged miceAging, 2020
  6. FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylationCommunications biology, 2025
  7. FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cellsExperimental gerontology, 2024

Ready to start with FOX-04?

Take our eligibility quiz to see if this treatment is right for you.

Start Intake